Publications in collaboration with researchers from Montreal Heart Institute (9)

2025

  1. Naxos Disease and Related Cardio-Cutaneous Syndromes

    JACC: Advances, Vol. 4, Núm. 2

2024

  1. Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

    eClinicalMedicine, Vol. 76

  2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

2023

  1. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial

    The Lancet, Vol. 402, Núm. 10396, pp. 118-128

2022

  1. Acute Myocarditis Associated With Desmosomal Gene Variants

    JACC: Heart Failure, Vol. 10, Núm. 10, pp. 714-727

  2. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

    Nature Genetics

  3. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

    Nature genetics, Vol. 54, Núm. 3, pp. 232-239

2021

  1. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

    Genetics in Medicine, Vol. 23, Núm. 1, pp. 47-58

2015

  1. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7